FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
CO:09:5 | LDL-cholesterol goal attainment with ezetimibe and bempedoic acid in patients with rheumatoid arthritis: a simulation study in the Italian CORDIS cohort Alessandro Giollo1, Kiren Khalid1, Luca Bonanni2, Nicola Ferri3, Gianluca Erre4, Matteo Piga5, Elena Bartoloni6, Andreina Manfredi7, Enno Giulio Favalli8, Maria Sole Chimenti9, Serena Guiducci10, Eleonora Celletti11, Addolorata Corrado12, Simone Parisi20, Ivan Giovannini13, Elisa Gremese14, Garifallia Sakellariou15, Ombretta Viapiana16, Marco Fornaro19, Fabiola Atzeni17, Francesca Romana Spinelli18, Fabio Cacciapaglia19 | 1Università di Padova Padova, Italy; 2UO Medicina Interna ULSS3 Mestre, Italy; 3Università di Padova, Department of Pharmaceutical and Pharmacological Sciences, University of Padova Padova, Italy; 4Università di Sassari Sassari, Italy; 5Università di Cagliari Cagliari, Italy; 6Univeristà degli studi di Perugia Perugia, Italy; 7Università di Modena e Reggio Emilia, UO di Reumatologia Ospedale Policlinico di Modena Reggio Emilia, Italy; 8IRCCS Humanitas Research Hospital, Rozzano Milano, Italy; 9Università Tor Vergata Roma, Italy; 10Università di Firenze Firenze, Italy; 11Ospedale SS. Annunziata Chieti, Italy; 12Università degli studi di Foggia Foggia, Italy; 13Università di Udine, Clinica di Reumatologia Udine, Italy; 14Università degli studi di Milano Milano, Italy; 15Università degli Studi di Pavia Pavia, Italy; 16Università di Verona Verona, Italy; 17Università degli Studi di Messina Messina, Italy; 18Università La Sapienza Roma, Italy; 19Università di Bari, Reumatologia Universitaria Policlinico di Bari Bari, Italy; 20S.C. di Reumatologia A.O.U. Città della Salute e della Scienza di Torino - Ospedale Molinette Torino, Italy
43 -
PO:07:103 | Tocilizumab use in patients with rheumatoid arthritis and malignancy: a monocentric experience Vittorio Dibenedetto1|2|3, Nicola Farina1|2, Nicola Boffini1|2, Alessandro Tomelleri1|2, Adriana Cariddi1|2, Elena Baldissera1|2, Marco Matucci-Cerinic1|2|3, Lorenzo Dagna1|2|3. | 1Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milano, Italy; 2Inflammation, Fibrosis and Ageing Intitiative INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy; 3Vita-Salute San Raffaele University, Milano, Italy.
217 -
PO:33:199 | Prevalence and clinical associations of antiphospholipid antibodies in patients with systemic sclerosis in the SPRING-SIR registry Antonio Tonutti1|2, Ilaria Cavazzana3, Angela Ceribelli1|2, Maria De Santis1|2, Giacomo De Luca4|5, Maria Grazia Lazzaroni3, Franco Franceschini3, Carlo Selmi1|2, Valeria Riccieri6, Silvia Laura Bosello7, Fabio Cacciapaglia8, Veronica Codullo9, Francesca Ingegnoli10, Dilia Giuggioli11, Rossella De Angelis12, Clodoveo Ferri11, Marco Matucci-Cerinic4|5 | 1Department of Biomedical Sciences, Humanitas Universityce Pieve Emanuele, Milan, Italy; 2Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy; 3Rheumatology and Clinical Immunology - ASST Spedali Civili Brescia - Department of Clinical and Experimental Sciences - Brescia, Italy; 4Vita-Salute San Raffaele University Milan, Italy; 5Unit of Immunology, Rheumatology, Allergy and Rare Diseases UnIRAR and INFLAGE Initiative, IRCCS San Raffaele Hospital Milan, Italy; 6University of Rome La Sapienza Rome, Italy; 7Catholic University of Sacred Heart Rome, Italy; 8LUM University Bari, Italy; 9Rheumatology Unit, Fondazione IRCCS Policlinico San Matteo Pavia, Italy; 10University of Milan Milan, Italy; 11University of Modena and Reggio Emilia Modena, Italy; 12Politechnic University of Marche Ancona, Italy
43 -
PO:33:195 | Evaluation of prevalence and role of anti-endothelin type a-receptor and anti-angiotensin ii type 1-receptor antibodies in a cohort of systemic sclerosis patients Clara Minerba1, Sara Ferrigno1, Antonella Grimaldi2, Noemi Aprile3, Daniela Costanza2, Laura Quarta2, Maria Rita Ricciardi2, Daniela Stasi3, Paola Conigliaro1, Alberto Bergamini1, Eugenio Quarta2, Maria Sole Chimenti1. | 1U.O.C. Reumatologia, Dipartimento di Medicina dei Sistemi, Università di, Roma, Tor Vergata, Roma, Italy; 2U.O.S.D. Reumatologia, P.O. Vito Fazzi Lecce Italy; 3U.O.C. Patologia clinica e Microbiologia, P.O. Vito Fazzi Lecce Italy.
176 -
PO:34:211 | Gynecological health and ultrasound evaluation among fertile women affected by Systemic sclerosis: an observational study Martina Orlandi1, Sofia Gambigliani Zoccoli2, Mariagrazia Nuara1, Riccardo Cuoghi Costantini2, Amelia Spinella1, Marco De Pinto1, Antonio La Marca2, Dilia Giuggioli1 | 1Dipartimento di Scienze Mediche e Chirurgiche, Università di Modena e Reggio Emilia, Italy; 2Dipartimento Materno Infantile. Università di Modena e Reggio Emilia, Italy
46 -
PO:25:073 | Pulmonary involvement and progressive interstitial lung disease in anti-synthetase syndrome: a single-center retrospective study Daniele Scaramuzzi1|3, Giacomo De Luca1|3, Veronica Batani1, Giulia Buonsante1|3, Lorenzo Dagna1|3, Marco Matucci-Cerinic1|2|3, Corrado Campochiaro1|2|3 | 1Unità di Immunologia, Reumatologia, Allergologia e Malattie Rare, IRCCS Ospedale San Raffaele, Milano; 2Inflammation, Fibrosis and Ageing Initiative INFLAGE, IRCCS San Raffaele Hospital, Milano; 3Università Vita-Salute San Raffaele, Milano, Italy
189 -
PO:24:065 | Nailfold capillaroscopic in primary Sjögren's syndrome, clinical and serological correlations; a preliminary report from a reference center Caterina Vacchi1, Filippo Santoro1, Maria Grazia Malandra1, Giulia Cassone1, Alessandra Carobbio2, Martina Orlandi1, Dilia Giuggioli1 | 1Reumatologia Modena, Italy; 2Statistica Medica Modena, Italy
47 -
PO:07:108 | Achievement of Treatment Targets and Maintenance of Response with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in a Real-world Setting: Final 2-year Outcomes from the UPHOLD Study Enrico Marchetta1, Andrew Östör2|8, Eugen Feist3, Prodromos Sidiropoulos4, Jérôme Avouac5, Martin Rebella6|7, Rajaie Namas9, Erin Mcdearmon Blondell10, Ivan Lagunes10, Tianming Gao10, Tim Shaw10, Suzan Attar11 | 1AbbVie Srl Roma, Italy; 2Monash University and Emeritus Research, Melbourne, Victoria, Melbourne, Australia; 3Helios Department of Rheumatology and Clinical Immunology, Vogelsang-Gommern, Vogelsang Gommern, Germany; 4Faculty of Medicine, University of Crete, Heraklion, Heraklion, Greece; 5Service de Rhumatologie, Hôpital Cochin, AP HP Centre Université Paris Cité, Parigi, France; 6Departamento de Medicina, Facultad de Medicina, Universidad de la República, Montevideo, Montevideo, Uruguay; 7Unidad de Enfermedades Autoinmunes Sistémicas, MUCAM, Montevideo, Montevideo, Uruguay; 8Australian National University, Camberra, Australia; 9Medical Subspecialties Institute, Division of Rheumatology, Cleveland Clinic Abu Dhabi, United Arab Emirates; 10AbbVie Inc., North Chicago, Illinois, United States of America Chicago, USA; 11King Abdulaziz University, Jeddah, Saudi Arabia
49 -
PO:27:105 | Sleep disturbances in patients with polymyalgia rheumatica: correlations with disease activity, fatigue, and glucocorticoid dosage Ilaria Franch1, Lorenzo Di Sanzo1, Chiara Castellani2, Giulia Bevignani1, Lucia Colella1, Veronica Alò1, Fabrizio Conti1, Rossana Scrivo1 | 1Università La Sapienza, Roma; 2Ospedale San Camillo De Lellis, Rieti, Italy
316 -
-
PO:31:165 | Prevalence and incidence of skin telangectasia and their association with clinical features: analysis of the European Scleroderma Trials and Research cohort Gemma Lepri1, Lorenzo Tofani2, Silvia Bellando Randone1, Veronica Batani3, Paolo Airò4, Patricia Carreira5, Joerg Henes6, Alexandra Balbir Gurman7, Florenzo Iannone8, Antonella Marcoccia9, Luc Mouthon10, Branimir Anic11, Carolina De Souza Müller12, Armine Haroyan13, Ana Cristina Cordeiro14, Serena Guiducci And Eustar Coll1. | 1University of Florence, Dept of Experimental and Clinical Medicine, AOU Careggi, Division of Rheumatology Florence Italy; 2University of Florence, Dept of Statistics, Informatics, Applications, Florence, Italy; 3Unit of Immunology, Rheumatology, Allergy and Rare Diseases UnIRAR, IRCCS San Raffaele, Milano, Italy; 4Scleroderma Unit, UOC Rheumatology and Clinical Immunology, ASST Spedali Civili, Brescia, Italy; 5Dept of Rheumatology, 12 de Octubre University Hospital, Madrid, Spain; 6Centre for Interdisciplinary Rheumatology, Immunology and autoimmune diseases INDIRA, University Hospital Tuebingen, Tuebingen, Germany; 7Rheumatology Institute, Rambam Health Care Campus Haifa Israel; 8Dept of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari, Italy; 9Interdisciplinary Reference Center for Systemic Sclerosis CRIIS Sandro Pertini Hospital, Rome, Italy; 10Dept of Internal Medicine, Cochin Hospital, Paris Cité University, Paris, France; 11Div Clinical Immunology and Rheumatology, Dept Internal Medicine, School of Medicine, University Hospital Center Zagreb, Zagreb, Croatia; 12Rheumatology Division, Hospital de Clínicas da Universidade Federal do Parana, Curitiba, Brazil; 13Dept of Rheumatology, Yerevan State Medical University of Armenia, Yerevan, Armenia; 14Servico Reumatologia Hospital Garcia de Orta Almada, Almada, Portugal.
204 -
PO:17:250 | Effectiveness and safety of the recombinant zoster vaccine in patients ≥18 years of age with systemic lupus Giulia Boschi1, Sheryl A. Kluberg2, Sophie E. Mayer2, O'Mareen Spence3, Driss Oraichi3, Harry Seifert3, Omar Ali3, Huifeng Yun3, Andrew L. Simon4, Jenice S. Ko4, Caroline Hugh4, Meg Her4, Kathleen Shattuck4, Richard Platt2, Aziza Jamal-Allial5, Djeneba Audrey Djibo6, Kimberly Daniels5, Qianli Ma7, Cheryl N. Mcmahill-Walraven6, Rachel P. Ogilvie8, Kristin Palmsten9, Mano Selvan7, Najat Ziyadeh8, Alexis Ogdie10, Michael George10 | 1GSK Verona Italy; 2Harvard Medical School and the Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston; 3GSK Rockville; 4Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston; 5Carelon Research, Wilmington; 6CVS Health, Blue Bell; 7Humana Healthcare Research, Louisville; 8OptumInsight Life Sciences, Boston; 9HealthPartners Institute, Bloomington; 10University of Pennsylvania, Philadelphia, USA
181 -
S02:5 | Combined anti-IL-5/IL-5r and dupilumab therapy in eosinophilic granulomatosis with polyangiitis: a European retrospective study Miriam Guerini1, Pavel Novikov2, Roberto Padoan3, Georgina Espigol Frigolé4, Jan Willem Cohen Tervaert5, Vincent Grobost6, Laurent Guilleminault7, Jan Walter Schroeder8, Bernhard Hellmich9, Joana Martins Martinho10, Camillo Ribi11, Matthieu Groh12, Benjamin Terrier13. | 1IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy; 2Sechenov University, Moscow, Russia; 3University of Padova, Padova, Italy; 4Hospital Clinic, University of Barcelona, Barcelona, Spain; 5University of Alberta, Edmonton, Canada; 6CHU Estaing Clermont-Ferrand France; 7Toulouse University Toulouse France; 8ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy; 9Medius Kliniken Kirchheim-Teck Germany; 10ULS Santa Maria, Lisbon, Portugal; 11Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; 12Hopital Foch, Suresnes, France; 13Service de Medecine interne, Hopital Cochin, AP-HP, Paris, France.
263 -
PO:25:075 | Cancer occurence in patients with idiopathic inflammatory myopathies: new insights from the analysis of a monocentric cohort Michele Diomedi1, Federico Fattorini1, Simone Barsotti2, Chiara Cardelli1|3, Elenia Laurino4, Alessandra Tripoli4, Linda Carli4, Marta Mosca1|4. | 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 2Rheumatology, Versilia Hospital, Viareggio, Italy; 3Department of Medical Biotechnologies, University of Siena, Siena, Italy; 4Rheumatology Unit, AOUP, Pisa, Italy.
196 -
PO:33:202 | Assessment of Retinal Arteriolar Wall-to-Lumen Ratio and Renal Resistive Index in patients with Systemic Sclerosis Eleonora Pazzi1|2, Elda Piovani1|2, Claudia Barison1|2, Liala Moschetti1|2, Eleonora Pedretti1|2, Mariagrazia Lazzaroni1|2, Carolina De Ciuceis3, Claudia Agabiti-Rosei3, Giacomo Buso3|4, Paolo Baggi3, Claudia Rossini3, Cristina Bevacqua3, Maria Lorenza Muiesan3, Ilaria Cavazzana1, Franco Franceschini1, Paolo Airò2 | 1Rheumatology and Clinical Immunology, ASST Spedali Civili of Brescia, University of Brescia, Brescia, Italy; 2Scleroderma Unit, ASST Spedali Civili of Brescia, Brescia, Italy; 3Department of Clinical and Experimental Sciences, Division of Internal Medicine, ASST Spedali Civili of Brescia, Univers Brescia, Italy; 4University of Lausanne, Lausanne Switzerland
44 -
PO:06:084 | Interstitial lung involvement in rheumatoid arthritis patients treated with abatacept: a prospective observational study Francesca Cozzini1|2, Andreina Manfredi2|3, Antonio Carletto4, Elisa Bellis5, Laura Cometi6, Vincenzo Venerito7, Caterina Vacchi8, Fabiola Atzeni9, Antonio Carriero10, Rosaria Foti11, Mariagrazia Catanoso3, Ennio Favalli12, Chiara Bazzani13, Arianna Belvedere3, Cecilia Burattini1, Andrea Morciano4, Annamaria Iagnocco5, Gemma Lepri6, Florenzo Iannone7, Antonio Pezzano9, Salvatore D'Angelo10, Valentina Cateni4, Serena Guiducci6, Marco Sebastiani1|14. | 1Ospedale Guglielmo da Saliceto, Piacenza, Italy; 2Università degli studi di Modena e Reggio Emilia, Modena, Italy; 3IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy; 4AOUI, Università degli studi di Verona, Verona, Italy; 5A.O. Mauriziano di Torino, Università degli studi di Torino, Torino, Italy; 6AOU di Careggi, Università degli studi di Firenze, Firenze, Italy; 7AOU Policlinico di Bari, università degli studi di Bari Aldo Moro, Bari, Italy; 8AOU Policlinico di Modena, Modena, Italy; 9AOU Gaetano Martino, Università degli studi di Messina, Messina, Italy; 10Azienda Ospedaliera Regionale San Carlo, Potenza, Italy; 11AO Vittorio Emanuele, Catania, Italy; 12ASST Gaetano Pini, Milano, Italy; 13ASST Spedali Civili, Brescia, Italy; 14Università degli studi di Parma, Parma, Italy.
217 -
PO:16:232 | Belimumab step-down dose spacing in patients with systemic lupus erythematosus in persistent clinical remission: experience from a multicentric cohort Alice Bartoletti1, Laura Giudice1, Lorenza Maria Argolini1|2, Giuseppe Alvise Ramirez3, Luca Moroni3, Tommaso Schioppo4, Chiara Bellocchi5|6, Annalaura Fasiello6, Lorenzo Beretta6, Lorenzo Dagna3, Roberto Caporali1, Maria Gerosa1. | 1UO Clinica Reumatologica, ASST Gaetano Pini CTO, Milano, Italy; 2UOC Medicina fisica e riabilitazione specialistica, ASST Gaetano Pini CTO, Milano, Italy; 3Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Vita-Salute San Raffa Milano Italy; 4Medicina Generale II, Servizio di Reumatologia, Ospedale San Paolo, ASST Santi Paolo Carlo, Milano, Italy; 5Department of Clinical Sciences and Community Health, University of Milan, Dipartimeto di Eccellenza 2023-2027, Milano, Italy; 6Referral Centre for Systemic Autoimmune DIseases, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy
233 -
PO:31:171 | Uncovering subclinical cardiac involvement in VEDOSS: An echocardiographic driven study Eugenio Capparelli1, Eleonora Zaccara1, Irene Rota2, Sara Facetti2, Daniela Bompane1, Laura Castelnovo1, Antonino Mazzone3, Paola Faggioli1 | 1UOC Reumatologia, ASST Ovest-Milanese, Legnano Milano Italy; 2UOC Cardiologia, ASST Ovest-Milanese, Legnano Milano, Italy; 3UOC Medicina Interna, ASST Ovest-Milanese, Legnano, Milano, Italy
31 -
PO:08:119 | Infusional Advantage: Rituximab’s Role in Enhancing Adherence in Multimorbid Rheumatoid Arthritis Marco Capodiferro1, Daniele Domanico1, Angelica Napoletano1, Giulia Righetti2, Patrizia Suppressa2, Vincenzo Venerito1, Giuseppe Lopalco1, Florenzo Iannone1, Fabio Cacciapaglia1|2 | 1Rheumatology Unit, Department of Precision and Regenerative Medicine and Jonian Area DiMePRe-J University of Bari, Italy; 2Department of Medicine and Surgery, Miulli General Hospital Acquaviva delle Fonti - LUM University Casamassima Bari Acquaviva delle Fonti, Bari, Italy
38 -
PO:23:055 | Overlap of systemic sclerosis and Sjögren’s disease: insights from an Italian case-control study Stefano Stano1, Fabio Cacciapaglia1|2, Maria Morrone1, Simone Perniola1, Marco Capodiferro1, Marco Fornaro1, Laura Coladonato1, Giuseppe Lopalco1, Florenzo Iannone1. | 1Rheumatology Unit - Department of Precision and Regenerative Medicine, Jonian Area DiPReMeJ, University of Bari, Bari, Italy; 2Rheumatology Service, Internal Medicine Unit F. Miulli General Hospital, Department of Medicine and Surgery, LUM Casamassima Italy.
285 -
PO:29:145 | Fibromyalgia in idiopathic inflammatory myopathies: is it time for rheumatologists to investigate it? Federico Fattorini1, Michele Diomedi1, Simone Barsotti2, Elenia Laurino3, Chiara Cardelli1|4, Alessandra Tripoli3, Linda Carli3, Marta Mosca1|3. | 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 2Rheumatology, Versilia Hospital, Viareggio, Italy; 3Rheumatology Unit, AOUP, Pisa, Pisa, Italy; 4Department of Medical Biotechnologies, University of Siena, Siena, Italy.
194 -
PO:15:217 | Improved efficacy and safety outcomes in patients with systemic lupus erythematosus treated with belimumab vs. immunosuppressants, in addition to antimalarials and glucocorticoids: a post-hoc summary of five phase 3 trials Mariele Gatto1, Karen H. Costenbader2, Andreas Schwarting3, Julia Hn Harris4, Ciara O'Shea5, Roger A. Levy6, Andrea Doria7 | 1Centro Accademico Reumatologia, Dipartimento Scienze Cliniche Biologiche, Università degli Studi Torino, Osp. Mauriziano, Italy; 2Brigham and Women's Hospital, Divisione di Reumatologia, Infiammazione e Immunità, Harvard Medical School, Boston, MA, USA; 3Università Johannes Gutenberg di Mainz, Centro medico universitario, Germany; 4GSK, Immunologia Biostatistica London, UK; 5GSK, Global Medical Affairs Reumatologia, Dublin, Ireland; 6GSK, Global Medical Affairs Collegeville, PA, USA; 7Divisione di Reumatologia, Dipartimento di Medicina, Università di Padova, Italy
201 -
PO:34:204 | Impact of anti-centromere antibodies on immunosuppressive therapy persistence in systemic sclerosis: a single-center case-control study Martina Salerno1, Marius Cadar1, Ilaria Bisconti1, Francesca Romana Di Ciommo1, Elena Platania1, Jacopo Landro1, Beatrice De Girolamo1, Davide Mohammad Reza Beigi1|2, Simona Truglia1, Fabrizio Conti1, Valeria Riccieri1 | 1Rheumatology unit, AOU and Università di Cagliari; 2Asl Biella, Ospedale degli Infermi, Ponderano (BI), Italy
210 -
PO:19:283 | Hospitalization profile and complications in patients with adult-onset Still’s disease: results from a retrospective study of 74 cases Chiara Calabrese1, Alessandro Tomelleri1|2, Corrado Campochiaro1|2, Nicola Farina2, Elena Baldissera2, Marco Matucci-Cerinic1|2, Lorenzo Dagna1|2 | 1Libera Università Vita-Salute San Raffaele, Milano; 2Unità di Immunologia, Allergologia e malattie rare, IRCCS San Raffaele, Milano, Italy
185 -
PO:34:205 | Optical coherence tomography angiography: a window on systemic sclerosis microangiopathy Martina Orlandi1, Tommaso Verdina2, Filippo Santoro1, Alessandra Carobbio3, Amelia Spinella1, Marco De Pinto1, Giorgia Roveta1, Dilia Giuggioli1 | 1Internal Medicine Residency Program, Marche Polytechnic University, Ancona; 2Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona; 3Department of Interna, Ancona, Italy
197 -
PO:12:180 | Echocardiographic screening of pulmonary hypertension in a multidisciplinary cohort of patients with interstitial lung disease Lorenzo Mattia Bianchessi1, Veronica Piccin1, Federica Sabatelli1, Lorenzo Cavagna1, Giovanni Zanframundo1, Domenicafederica Briganti2, Mauro Acquaro3, Stefano Ghio3, Domenico Sorace1, Valentina Vertui2, Ilaria Giana2, Andrea Patanè3, Veronica Codullo1 | 1UOC Reumatologia, Fondazione IRCCS Policlinico S. Matteo, Pavia; 2Centro Trapianti, Fondazione IRCCS Policlinico San Matteo, Pavia; 3UOC Cardiologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
198
